ArticleNature chemistry2026
Enantioconvergent vinylcyclopropane-cyclopentene rearrangement with vessel-controlled chemodivergence.
Article in Nature chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vessel material determines product of enantioselective vinylcyclopropane rearrangement.Nature chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vinylcyclopropane-cyclopentene (VCP-CPent) rearrangement serves as a fundamental method for constructing five-membered carbocycles from vinylcyclopropanes. However, achieving enantioconvergent rearrangement of less activated VCPs remains a formidable challenge. Here we report a strategy to achieve enantioconvergent VCP-CPent rearrangement of vinyl gem-difluorocyclopropanes. Our strategy proceeds through a key vinyl fluoroallyl rhodium intermediate that is mechanistically distinct from those in previously reported pathways. Furthermore, we discovered a vessel-controlled chemodivergence in this rearrangement: the reaction forms gem-difluorocyclopentenes in plastic tubes and cyclopentenones in glass vials. This protocol demonstrates excellent chemoselectivity and enantioselectivity, delivering both products in high yields with excellent e.e. values. These products, which are difficult to synthesize by conventional methods, represent privileged scaffolds in synthetic and medicinal chemistry. Mechanistic investigations offer insights into this enantioconvergent rearrangement pathway and vessel-effected chemodivergence. In addition, preliminary biological activity study shows potential of gem-difluorocyclopentene as cyclopentenone bioisostere in medicinal chemistry.
Indexed as
Identifiers
41998413What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.